Exploring the Efficacy of Alirocumab and Evolocumab in Reducing Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients With Familial Hypercholesterolemia: A Systematic Review

Patients with familial hypercholesterolemia (FH) have an increased risk of having abnormally high low-density lipoprotein cholesterol (LDL-C) levels. One of the main groups of drugs used for FH is statins. However, even with statins, most patients with FH do not achieve their pre-defined therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luthra, Gaurav, Shahbaz, Mahrukh, Almatooq, Halah, Foucambert, Paul, Esbrand, Faith, Zafar, Sana, Panthangi, Venkatesh, Cyril Kurupp, Adrienne R, Raju, Anjumol, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547534/
https://www.ncbi.nlm.nih.gov/pubmed/36237809
http://dx.doi.org/10.7759/cureus.28930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547534/
https://www.ncbi.nlm.nih.gov/pubmed/36237809
http://dx.doi.org/10.7759/cureus.28930

Ejemplares similares